chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had itching on my neck at the base of my hairline and then behind my ears; hives on torso that spread to my wrist, then inner elbow, inner thigh and eyelids; This is a spontaneous report from a contactable consumer reporting for herself. A 35-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EM9810/expiration date: not provided), via an unspecified route of administration, on 13Feb2021 at 13:00 (at the age of 35 years old) as a single dose in the left arm for COVID-19 IMMUNIZATION. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number: FL3246/expiration date: not provided), via an unspecified route of administration, on 23Jan2021 at 13:00 (at the age of 35 years old) as a single dose in the left arm for COVID-19 IMMUNIZATION. Relevant medical history was not reported. It was unknown if the patient had any allergies. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant was reported as none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 16Feb2021 at 12:45, the patient experienced itching and hives. The clinical course was as follows: "I had itching on my neck at the base of my hairline and then behind my ears and then noticed hives on torso that spread to my wrist, then inner elbow, inner thigh and eyelid". It was reported whether treatment was received for the events was unknown. The outcome of the events itching and hives was recovering. Since the vaccination, the patient had not been tested for COVID-19.
This spontaneous report as received from a registered nurse (R.N.) refers to a patient of unknown age and gender. On 23-MAY-2013 the patient was vaccinated with the first dose of GARDASIL (Lot #, dose and route not reported) and on 30-MAY-2013 was vaccinated with the second dose of GARDASIL (Lot #, dose and route not reported). Concomitant therapy was not reported. No adverse event reported. Additional information is not expected.
panniculitis; severe induration; This case was reported by a nurse via sales rep and described the occurrence of panniculitis in a adolescent female patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   Previously administered products included Boostrix with an associated reaction of panniculitis (received 1st dose of and experienced Panniculitis, refer case US2022082817).   On an unknown date, the patient received Boostrix. On an unknown date, unknown after receiving Boostrix, the patient experienced panniculitis (serious criteria GSK medically significant) and induration. Rechallenge with Boostrix was positive. On an unknown date, the outcome of the panniculitis and induration were unknown.   It was unknown if the reporter considered the panniculitis and induration to be related to Boostrix.     Linked case(s) involving the same patient:  US2022082817   Additional Information: GSK Receipt Date: 23-May-2022 Reporter's Comments: The reporter stated that the patient received second dose of Boostrix on unknown arm and very soon after developed severe induration and panniculitis No further details provided. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022082817:Same reporter
Diagnosed with iritis on Jan 25. I had had irritated eyes since having covid (diagnosed on Nov 17, fairly ill) so I am not sure if had iritis before, but definitely became more symptomatic after getting vaccine, formally seen by OD on Jan 25 and diagnosed with iritis of both eyes, right greater than left. I also had symptoms post vaccine x 3 days of chills, headache, myalgias, nausea and diarrhea (same symptoms I had with covid). Treatment for iritis ocular steroids, treatment ongoing.
Started getting a localized allergic reaction on the Left arm near the injection site. Arm became red, swollen, and itchy.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Hypotension-Severe, Systemic: Visual Changes/Disturbances-Medium, Additional Details: WITHIN 5 MINUTES OF ADMINISTRATION, PATIENT FELT LIGHT HEADEDNESS, COMPLAINTS THAT SHE COULDN'T SEE. LAID PATIENT DOWN WITH LEGS UP, BLOOD PRESSURE WAS LOW. MONITORED FOR 45 MINS & SLOWLY MOVED TO SITTING, THEN STANDING POSITION. PATIENT FELT BETTER. FOLLOW UP CALL AT 6:15PM AND NO COMPLAINTS OF ADDITIONAL REACTIONS.
Systemic: Allergic: Rash (specify: facial area, extremities)-Severe, Systemic: Flushed/Sweating-Severe, Systemic: Unable to Sleep-Medium, Additional Details: After receiving the Pfizer vaccines, patient's face broke-out in acne-like blemishes. Patient's face is red and inflamed. She went to the dermatologist. They diagnosed her with dermatitis.
Myalgia started 6 hours after dose, chills started 9 hours after dose. The next day develop fever up to 101.7 (which was lower than after my 3rd vaccine (up to 103.5).  Today (two days after vaccine) developed sores and blister behind my upper incisors and top of palate. Tender but not painful. Makes it difficult to eat.
Patient reported itching, swelling, soreness, and tightness of arm around inject site that night and throughout the night. Started to occur late afternoon, swelling started to subside the following morning. Patient self-treated with BENADRYL cream, and I advised patient to take BENADRYL tablet as well. Pt was noticing swelling reduced the next morning.
patient called the pharmacy complaining about having swollen & red left arm. advised her to contact her pcp or go to the er if it worsens. in the afternoon, patient came in to the pharmacy and said she called her dr's office and was told " to put an ice pack on it and if it does still worsen she needed to be seen "
skin redness, swelling left upper thigh 4cm x6cm diameter appeared 6- 8 hrs after receiving the 4 year old vaccines, Kinrix and Proquad. Kinrix given on the left upper thigh. No systemic reaction reported like difficulty swallowing, breathing difficulty, swelling of face or rash on any other parts of the body. no labs for allergic reaction
64 Yr old with mild GBS 4 days after receiving flu shot. Pt could barely walk; his legs were asleep up to his waist. Tx w/ shock treatments and dxed w/ GBS.
Diagnosed and hospitalized for COVID 19. Patient self reported full vaccinated. Patient from out of state.
Patient was given immunization on 07/07/17 in right arm (IM). Patient went to E.R. last night due to arm swelling over the pass couple of days. Patient was given Doxycycline as an antibiotic at the E.R. and as a prescription. Patient said since starting Doxycycline her arm as gotten a little better. Today (07/10/17), patient picked up Rx for the Doxycycline.
At 1615 Patient reported symptoms after coivd19 vaccine Pfizer 2nd dose. With left arm rash, warm to touch and numbness. Same symptoms were reported by patient after receiving the first dose coivd19 vaccine Pfizer.  Adverse reactions were reported to  Dr. and RN. for further medical intervention  As per Dr. orders,  Benadryl 25 mg IM.
The vaccinated arm became itchy and swollen exactly one week after injection.  The itching dissipated within a week, but my arm eventually became swollen, lumpy, and inflamed from my shoulder to my elbow and lasted for another couple of weeks.
Day after vaccine administered, patient developed redness and swelling at injection site. The next day swelling, redness, itching and heat increased. Swelling radiated about 4 inches up and 6 inches across. In the next few days, patient experience lethargy, malaise, stomach upset, headache, and flu-like symptoms. On day 6, patient called the pharmacy and asked us to submit a report. At this point, patient was advised to take acetaminophen and ice the area for 15 minutes 3 times daily. As of today, symptoms are slowly resolving.
Due to reaction was seen at local Urgent Care (on 11/14/19) and was started on Septra 15ml's BID. Presented for a re-check in office on 11/20/19. No redness, tenderness noted, not tender to palpation, mild edema to left deltoid. Recommended complete course of Septra and apply warm compress as needed, for increased redness, tenderness or swelling return for re-check in office.
This spontaneous report as received from a medical assistant, referring to a unspecified number of patients of unknown genders and ages. No information regarding the patients' medical history, concurrent conditions or concomitant therapies was provided. On an unknown date, the patients were vaccinated with improperly stored dose of VARIVAX Lot number M034584, expiration date 27-JUL-2018 (strength and route were not reported) for prophylaxis, and other VARIVAX vaccine which had a lot # L020004 with expiration date on 02-JUN-2017 , however no adverse effects were reported. It was mentioned that the vaccines were exposed to temperature of >-10 C but <8 Centigrade range for a time frame of 1 hour and 4 minutes. The temperature excursion was recorded by a data logger and no previous excursions were reported for the vaccines. There was no product quality complaint involved. This is one of the several reports received from the same reporter.  Additional information has been requested.; Sender's Comments:  US-009507513-1703USA008046: US-009507513-1703USA008047: US-009507513-1703USA008048: US-009507513-1703USA008049: US-009507513-1703USA008050: US-009507513-1703USA008051: US-009507513-1703USA001827:
tingling/numbness in left hand, traveled up the arm; Tingling/numbness in left hand, traveled up the arm/ Skin on jaw went numb for an hour/ recurring along with all over the body; lips began to go numb; left wrist felt as if it was filled with fluid with no visible swelling; Pain on the back of the left hand is intense and unrelenting.; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6208) via an unspecified route of administration, on 17Mar2021 at 3:00 PM (at the age of 36-years-old, not pregnant) as a single dose in the left arm for COVID-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing. No known allergies. There were no concomitant medications. No other vaccine in four weeks and no other medications in two weeks administered. On 18Mar2021 at 3:45 PM, the patient experienced tingling/numbness in left hand, traveled up the arm, lips began to go numb. The left wrist felt as if it was filled with fluid with no visible swelling. This has traveled all over various parts of the body. Skin on jaw went numb for an hour. Hand numbness was recurring along with all over the body at differing times. Pain on the back of the left hand is intense and unrelenting. The adverse events reported resulted in emergency room/department or urgent care, hospitalization. The patient was hospitalized for one day on an unspecified date in 2021. The treatment administered for the reported events were Benadryl and Pepcid via intravenous (IV) route. The outcome of the events was not recovered.
nausea; vomiting; joint pain; stomach pain; This case was reported by a consumer and described the occurrence of nausea in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th January 2023, the patient received the 1st dose of Shingrix. On 6th January 2023, 1 days after receiving Shingrix, the patient experienced nausea, vomiting, joint pain and stomach pain. On an unknown date, the outcome of the nausea was not recovered/not resolved and the outcome of the vomiting, joint pain and stomach pain were recovered/resolved.   It was unknown if the reporter considered the nausea, vomiting, joint pain and stomach pain to be related to Shingrix.     Additional Information: GSK receipt date: 09-JAN-2023 Reporters comment: The reporter was the patients wife ,she reported that her husband received first dose of shingrix vaccine and experienced nausea vomiting stomach pain and join pain. The reporter did not consent to follow up. Additional Supportive Information: This case is linked with case US2023002194 reported by same reporter.; Sender's Comments:  US-GSK-US2023002194:same reporter
Half dose was administered; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Half dose was administered) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 ml. On 07-Dec-2021, the patient experienced UNDERDOSE (Half dose was administered). On 07-Dec-2021, UNDERDOSE (Half dose was administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Dizziness, blurred eye vision, left arm numb, tight chest, joint/muscle aches, irregular heartbeat, fatigue, neck pain, jaw/lip numbness (turns purple), fainting, memory loss
Sore arm at injection site, headache, body aches, nausea, chills, chest pain, shortness of breath upon little exertion, fatigue, general malaise, pain in left armpit
This spontaneous report as received from a registered pharmacist refers to a 60 year old female patient. There was not pertinent medical history or drug reactions/allergies. On Sunday 28-JUL-2013, the patient was vaccinated with one dose of ZOSTAVAX (lot # not provided) 0.65 ml, subcutaneous. There were not concomitant medications. On Monday 29-JUL-2013, the patient was seen at her physician's office for treatment of cellulitis. There were not laboratory tests performed. The patient was given KEFLEX for the treatment of the event. At the time of the report, the outcome of cellulitis was recovering. The reporter considered the cellulitis to be medically significant. Additional information has been requested.
Headache; Pain in the left arm; This is a spontaneous report from a contactable consumer (patient).  A 59-year-old non-pregnant female patient received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL3247), via an unspecified route of administration in the left arm on 25Jan2021 at 14:30 at 59-years-old at a single dose for COVID-19 immunization; administered in an unspecified facility (reported as "other").  The patient medical history was not reported. The patient did not have allergies to medications, food, or other products. Concomitant medications were unspecified; and the medications were received within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 26Jan2021 at 04:15, the patient experienced headache (non-serious) and pain in the left arm (non-serious); for which no treatment was received.  The patient underwent lab tests and procedures which included polymerase chain reaction (PCR): negative on 21Dec2020, Nasal Swab (SARS-CoV-2 test): negative on 21Dec2020.  The clinical outcome of the events was unknown. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19; no results were provided.
pt was administered DT/TB tine test & exp a local reaction; reaction described as red & papular which extended to the lt thigh (knee to hip) & lt arm (hand to shoulder);
Sore arm; little fatigue; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and FATIGUE (little fatigue) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN, AMLODIPINE, LOSARTAN, MONTELUKAST, HYDROCODONE, METOPROLOL, LINAGLIPTIN (TRADJENTA) and CLONIDINE for an unknown indication.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (little fatigue). On 16-Apr-2021, PAIN IN EXTREMITY (Sore arm) and FATIGUE (little fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information does not provided.   This case was linked to MOD-2021-128053 (Patient Link).
Information has been received from a physician concerning a female who was vaccinated with the first dose of GARDASIL vaccine (yeast) (lot# not reported) on an unspecified date. "1 week later" the patient experienced bilateral axillary neck edema. "The edema lasted a few days and then resolved." No additional AE information was reported. Additional information has been requested.
Hot, red, localized 4 cm x 2 cm area at injection site with chills, headaches, stiff muscles, stiff neck within 1 hour.
pt states she has had a nerve pain and heavy feeling to her arm since the injection. she says it flares up every few day.
Headaches; little bit of congestion; sore throat; body aches; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 01Apr2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, the patient experienced headaches, little bit of congestion, sore throat and body aches. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. On 17Apr2021, the patient underwent COVID-19 PCR, nasal swab test and the result was negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events headaches, little bit of congestion, sore throat and body aches was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Pt received TDAP on (R) upper arm on 1/17/11 by evening (5 hours later) had 2cm area of erythema, swelling 7cm and 8cm of erythema, warmth and mild redness.
This spontaneous report as received from an other refers to an unspecified number of patients of unknown ages and genders. On an unknown dates, the patients were vaccinated with improperly stored doses of ZOSTAVAX lot # M041182 for prophylaxis. Concomitant therapies included sterile diluent. On an unknown date, the patients experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event was unknown. The reporter considered incorrect product storage and no adverse event to be not related to ZOSTAVAX. This is one of two reports from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1708USA012368.
Information has been received from an RN concerning a 65 year old Caucasian female who on 11/9/01 was vaccinated with a dose of pneumococcal vaccine 23 polyvalent. There was no illness at the time of vaccination. Subsequently, about 6-8 hours, post vax, the pt developed a fever, weakness, muscle aches, injection site redness and soreness, chills, a rash, a swollen arm and dyspnea. On 11/15/01, the pt was admitted to the hospital. While hospitalized, she was treated with steroids and antibiotics. The pt was discharged on 11/18/01 with a dx of adverse drug reaction and exacerbation of COPD. It was noted that the pt had a visit at the doctor's office since her discharge and all her symptoms had resolved except the dyspnea, which was being treated with portable oxygen that was used at night. Follow up information indicated that the patient recovered in December 2001. As of 2/23/02 she had no complaints of the symptoms.
Unspecified adverse reaction; This spontaneous report was received from a physician via a company representative, concerning a female patient of unknown age. The patient's concurrent conditions and medical history, as well as concomitant medications, were unknown.  On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (strength, dose, frequency, route, anatomical site, lot# and expiration date were not reported).  On an unknown date, the patient experienced an unspecified adverse reaction after administration of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) that led her to visit unspecified emergency room. It was unknown whether the patient was admitted to the hospital.  The outcome of the unspecified adverse reaction was unknown.  The reporter considered the unspecified adverse reaction to be related to HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast)(GARDASIL 9).
I was dizzy after the vaccine, but I left and took the bus and after 10 minutes of walking I lost my balance and fell, skinning my knee and thigh. I got home and raised my leg so that I wont bleed and the next day it was better, but I fell again at home; I had difficulty walking and over time (2 months) it got better, but in November I lost balance again, I fell several times, and I went to the doctor and the Neurologist told me it was the Nerve but nothing to do with the vaccine.
Red, swollen, feverish, sometimes itchy, a little bit painful to the touch- area on and surrounding the injection site. Approximately 4.5" by 3" surrounding the injection site.
Cant sleep; This is a spontaneous report from a contactable consumer. A male patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration on 29Jan2021 as single dose for COVID-19 immunisation. The patient's medical history included sinus headache on 29Jan2021. The patient's concomitant medications were not reported. The patient had sinus headache on 29Jan2021 before the vaccination and hence he took 500mg Tylenol. Afterwards, the patient had his vaccine dose and realised he made a mistake as he had read online that "it was bad to do and not supposed to take Tylenol before getting the vaccine" and "if the person takes Tylenol or a NSAID it can stop the immune response to the Pfizer vaccine". The patient further clarified that he did not have a reaction of any sort, he had no redness, headache or fatigue. The patient went on to describe that that, "he can't sleep at night thinking about that." The patient wanted to know whether he had to take the vaccine again and was wondering whether having taken Tylenol prior to the shot messed it up. Like in terms of getting the proper response from the vaccine, should he take an extra shot or not. The patient further stated that, the vaccine was perfectly safe, and Pfizer did great. The reporter had classified the events as non-serious. The outcome of the events was unknown.  Information on the lot/batch number has been requested. Follow-up attempts completed. No further information expected.
MD recv 3 reports of children who devel diarrhea p/vax;the reporter declined to provide further & declined to grant permission for f/u investigation;
it was rpt fr mom of pt who was vax & subsequently exp whole body swollen up.
Erythema and edema, warm to touch, measuring 6x7 cm oval on right deltoid.
Swelling about 2inches in diameter, redness, itching, soreness at injection site
Accidental second influenza vaccine given approximately 1 month after first was administered. Immediately noted and reported to Nursing supervisor. Patient was present in the Health Center without any adverse reaction noted.
Hospitalized 8/17 with fever, right lower lobe infiltrate and ++COVID 19 testing.
PATIENT STATES THAT AFTER GETTING HER 2ND DOSE OF MODERNA VACCINE ON 9/17 SHE EXPERIENCED SWOLLEN LYMPH NODES UNDER HER ARM AND UP HER NECK. SHE IS ALSO REPORTING INTCHING.